Save for a few minutes early on in the session, the Switzerland market languished in negative territory on Thursday as investors remained reluctant to make significant moves, digesting the central bank's rate decision, and closely following geopolitical news.
The benchmark SMI ended with a loss of 49.41 points or 0.36% at 13,765.83 after scaling a high of 13,836.55 and a low of 13,743.43 intraday.
Drugmakers Roche (down 2.68%) and Novartis (down 2.45%), were the major losers in the benchmark index. Partners Group drifted down nearly 2%, while Sandoz Group ended 1.6% down.
For comments and feedback contact: editorial@rttnews.com
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.